These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
472 related articles for article (PubMed ID: 12032582)
1. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders. Emmi L; Chiarini F Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582 [TBL] [Abstract][Full Text] [Related]
2. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. Ballow M J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies. Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663 [TBL] [Abstract][Full Text] [Related]
4. [Mechanisms of immunoglobulins activity]. Kowalczyk D Pol Merkur Lekarski; 2011 Jun; 30(180):397-9. PubMed ID: 21751546 [TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders. Mobini N; Sarela A; Ahmed AR Ann Allergy Asthma Immunol; 1995 Feb; 74(2):119-28; quiz 128-33. PubMed ID: 7697470 [TBL] [Abstract][Full Text] [Related]
9. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases. Mouthon L; Kaveri S; Kazatchkine M Transfus Sci; 1994 Dec; 15(4):393-408. PubMed ID: 10155557 [TBL] [Abstract][Full Text] [Related]
10. Modulation of the cellular immune system by intravenous immunoglobulin. Tha-In T; Bayry J; Metselaar HJ; Kaveri SV; Kwekkeboom J Trends Immunol; 2008 Dec; 29(12):608-15. PubMed ID: 18926775 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Gürcan HM; Ahmed AR Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006 [TBL] [Abstract][Full Text] [Related]
14. Increased blood plasma concentrations of TGF-beta1 and TGF-beta2 after treatment with intravenous immunoglobulins in childhood autoimmune diseases. Rissmann A; Pieper S; Adams I; Brune T; Wiemann D; Reinhold D Pediatr Allergy Immunol; 2009 May; 20(3):261-5. PubMed ID: 18761651 [TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of action of intravenous immunoglobulins in the treatment of autoimmune diseases]. Mouthon L; Hurez V; Kazatchkine M Ann Med Interne (Paris); 1993; 144(8):506-13. PubMed ID: 8179238 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg? Lamoureux J; Aubin E; Lemieux R Int Immunol; 2004 Jul; 16(7):929-36. PubMed ID: 15159376 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Bayry J; Thirion M; Misra N; Thorenoor N; Delignat S; Lacroix-Desmazes S; Bellon B; Kaveri S; Kazatchkine MD Neurol Sci; 2003 Oct; 24 Suppl 4():S217-21. PubMed ID: 14598046 [TBL] [Abstract][Full Text] [Related]
19. [Old and current aspects of intravenous immunoglobulin therapy]. Nydegger U Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191 [TBL] [Abstract][Full Text] [Related]